This HTML5 document contains 21 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n9http://dbkwik.webdatacommons.org/resource/35Fqr_wR-uopOUhBlEF-Qg==
n15http://dbkwik.webdatacommons.org/resource/41M8fembgW4ejRUqT-lkRA==
n12http://dbkwik.webdatacommons.org/ontology/
n13http://dbkwik.webdatacommons.org/speedydeletion/property/
n7http://dbkwik.webdatacommons.org/resource/Z7iLtiq_a6P0F6jqMJN4iQ==
n11http://www.manros-therapeutics.com/en/%7CManRos-Therapeutics.
foafhttp://xmlns.com/foaf/0.1/
n2http://dbkwik.webdatacommons.org/resource/Nwsepgt-yTXBJnFHJoHTRA==
n19http://dbkwik.webdatacommons.org/resource/Wdl7335Kn968i4GfqYcuLw==
n24http://dbkwik.webdatacommons.org/resource/yTb5WbS7dBCN1CYbxmA27w==
n26http://dbkwik.webdatacommons.org/resource/yeWv3YNTSuTNUAWbTAJQ2g==
rdfshttp://www.w3.org/2000/01/rdf-schema#
n16http://dbkwik.webdatacommons.org/resource/WzE93mOSb9LH4GSIxgd19g==
n14http://dbkwik.webdatacommons.org/resource/ySHBKhh22OetaUw-h-4ojw==
n21http://dbkwik.webdatacommons.org/resource/f_GHGC34L5SOqxftJ0ok_g==
n22http://dbkwik.webdatacommons.org/resource/G4qIUW8wKFQ2UnLJXakg9Q==
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dbkwik.webdatacommons.org/resource/noU-tisq6NJE-ZLSXYr-aA==
n4http://dbkwik.webdatacommons.org/resource/FUzCwyRJQduceus7pks-1A==
n17http://dbkwik.webdatacommons.org/resource/YEDuk5Aha-csqYQl1Cqe9g==
n23http://dbkwik.webdatacommons.org/resource/ehEb22dLwKZbz_xK2oEn5g==
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://dbkwik.webdatacommons.org/resource/m5268hoCy0FopVdhvAYd7w==
n5http://dbkwik.webdatacommons.org/resource/SiDw-rMsoFvg65m1RnMJIg==
n20http://dbkwik.webdatacommons.org/resource/rM-zjRLuYDR05YK0gAmHUQ==
n25http://dbkwik.webdatacommons.org/resource/VhD68UCbkWYgWNVf76BEug==
n18http://dbkwik.webdatacommons.org/resource/yyP1eToPjYQ_eaLglQOaQQ==
Subject Item
n2:
rdf:type
n15:
rdfs:label
ManRos Therapeutics
rdfs:comment
ManRos Therapeuticshttp://www.societe.com/societe/manros-therapeutics-498560861.html is a pharmaceutical company developing protein kinase inhibitors. Protein kinases are interesting targets for the development of new active drugs against diseases. The diseases targeted by ManRos Therapeutics are cancers, leukemia, neurodegenerative diseases and some kidney diseases.
n7:
Roscovitine
foaf:homepage
n11:com
n13:wikiPageUsesTemplate
n14: n16: n17: n18: n21: n22: n23:
n6:
ManRos Therapeutics
n5:
11
n20:
Worldwide
n4:
Laurent Meijer
n8:
n9:
n25:
n26:
n19:
CNRS
n24:
Hôttel de recherche perharidy, Roscoff, Finistère, France.
n12:abstract
ManRos Therapeuticshttp://www.societe.com/societe/manros-therapeutics-498560861.html is a pharmaceutical company developing protein kinase inhibitors. Protein kinases are interesting targets for the development of new active drugs against diseases. The diseases targeted by ManRos Therapeutics are cancers, leukemia, neurodegenerative diseases and some kidney diseases.